1 BTC
=
- USD
Waters Corp
As of May 30, 2026 at 24:05 UTC
Chart
About Waters Corp
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.
Market Statistics
Trading Metrics
How to Buy WAT
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy WAT
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesBecton Dickinson (BDX) trades at a 13x forward P/E multiple, representing a significant discount to medtech peers despite strong fundamentals including 60% U.S. infusion pump market share, 90%+ recurring revenue, and record 25% adjusted operating margins. The post-spin-off transition year narrative masks an emerging pure-play MedTech company with billion-dollar growth platforms in GLP-1 drug delivery and connected care, supported by $4 billion in fresh capital deployment and ongoing margin expansion targeting 26%+ territory.
Becton Dickinson reported Q1 2026 adjusted earnings of $2.91 per share, beating consensus of $2.81, with sales of $5.25 billion slightly above the $5.15 billion consensus. However, the company significantly lowered its fiscal 2026 adjusted earnings guidance to $12.35-$12.65 per share from $14.75-$15.05, citing transition year headwinds in China, vaccines, and Alaris. Multiple analysts cut price targets, with RBC reducing its forecast from $210 to $172, Wells Fargo from $184 to $157, and Piper Sandler from $205 to $170. BDX shares fell 17.44% to $171.23.
Software stocks extended their rebound with the iShares Expanded Tech-Software Sector ETF jumping over 3%, while the Nasdaq 100 climbed 1% and S&P 500 added 0.7%. Silver led commodities with a 6% rally to $82, while oil jumped 2% and gold rallied 2.5%. Notable gainers included AppLovin Corp surging 14%, Oracle rising 11%, and Palantir Technologies up 7%. Crypto markets lagged with Bitcoin slipping 0.4% to $70,000.
Waters Corporation reported Q4 2025 earnings that beat expectations with $932.36M in sales (7% growth) and $4.53 EPS versus consensus of $4.51. However, the stock fell 9.61% on Monday due to weaker-than-expected Q1 2026 guidance of $2.25-$2.35 EPS (vs. consensus $2.52) and conservative full-year 2026 outlook, despite management's optimism about momentum continuing into 2026.
Becton Dickinson reported Q1 2026 adjusted earnings of $2.91 per share, beating consensus of $2.81, with sales of $5.25 billion slightly above expectations. However, the company significantly lowered its fiscal 2026 adjusted earnings guidance from $14.75-$15.05 per share to $12.35-$12.65 per share, well below the consensus of $14.72. The guidance cut follows the company's spinoff and combination of its Biosciences and Diagnostic Solutions business with Waters Corporation.